Countries citing papers authored by Merrill J. Egorin
Since
Specialization
Citations
This map shows the geographic impact of Merrill J. Egorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merrill J. Egorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrill J. Egorin more than expected).
Fields of papers citing papers by Merrill J. Egorin
This network shows the impact of papers produced by Merrill J. Egorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merrill J. Egorin. The network helps show where Merrill J. Egorin may publish in the future.
Co-authorship network of co-authors of Merrill J. Egorin
This figure shows the co-authorship network connecting the top 25 collaborators of Merrill J. Egorin.
A scholar is included among the top collaborators of Merrill J. Egorin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Merrill J. Egorin. Merrill J. Egorin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ramanathan, Ramesh K., Merrill J. Egorin, Charles Erlichman, et al.. (2007). Phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, (17DMAG, NSC 707545), an inhibitor of heat shock protein 90 (HSP90), in patients with advanced solid tumors: Final results.. Molecular Cancer Therapeutics. 6.2 indexed citations
Florian, Jeffry, William C. Zamboni, Julie L. Eiseman, et al.. (2006). A physiologically-based pharmacokinetic (PBPK) model of docetaxel in SCID mice bearing SKOV3 human ovarian cancer xenografts. Cancer Research. 66. 730–730.1 indexed citations
Glantz, Michael, H. Choy, Wallace Akerley, et al.. (1997). Weekly paclitaxel with and without concurrent radiation therapy: Toxicity, pharmacokinetics, and response. Seminars in Radiation Oncology. 7.7 indexed citations
14.
Egorin, Merrill J.. (1993). Cancer pharmacology in the elderly.. PubMed. 20(1). 43–9.58 indexed citations
Egorin, Merrill J., et al.. (1990). Effects of ethanolamine and choline on thiotepa cellular accumulation and cytotoxicity in L1210 cells.. PubMed. 50(14). 4322–7.13 indexed citations
17.
Belani, Chandra P. & Merrill J. Egorin. (1990). Carboplatin dose optimization (I: Reply). Journal of Clinical Oncology. 8(7). 1284–1285.3 indexed citations
18.
Egorin, Merrill J., et al.. (1987). Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites.. PubMed. 47(22). 6142–6.9 indexed citations
19.
Egorin, Merrill J., David A. Van Echo, Margaret Whitacre, et al.. (1985). Human Pharmacokinetics and Correlation With Clinical Toxicities of the Anthracycline Antibiotic Menogaril (7-Omen). Journal of Bioresource Management. 26. 155.3 indexed citations
20.
Egorin, Merrill J., et al.. (1979). Cellular accumulation and disposition of aclacinomycin A.. PubMed. 39(11). 4396–400.19 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.